INS and hypertriglyceridemia: This approval was based on results from an NIH open-label, single-arm study of 48 patients with congenital, or acquired generalized lipodystrophy, who also had diabetes mellitus, hypertriglyceridemia, and/or elevated levels of fasting insulin [46].